Some patients with left ventricular systolic dysfunction (LVSD) have a dramatic improvement in left ventricular ejection fraction (LVEF) after beta-blockade.
Rate control of atrial fibrillation (AF) has become a main treatment modality, but we need more knowledge regarding the different drugs used for this purpose.
Objective In recent years, safety alerts have been made warning of the risk of serious drug-induced liver injury (DILI) caused by cardiovascular drugs.
Professor Evgeny Shlyakhto, MD, PhD, FESC, FACC, President of the Russian Society of Cardiology joined the European Heart Journal (EHJ) as an editorial board member in January 2014.
This is the second forum of young cardiologists which is organized in Russia. It is radically different from the first forum which was in Samara in 2012 due to form and content.
Данный сайт и вся информация на нём предназначена для медицинских работников.
Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.